1.
Ann Hematol
; 66(5): 267-8, 1993 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-7685195
RESUMO
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has been used mainly for treatment of chemotherapy-induced neutropenia. The reported side effects were of minor importance. We describe a case of long-term treatment with rhG-CSF, in which we observed enhanced bone remodeling.